Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction – CNBC By Weight Loss Haven Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction CNBC Novo Nordisk Says Wegovy Weight-Loss Pill Matches Shot as it Eyes Landmark Approval The Wall Street Journal Novo Nordisk shares shoot up amid promising results for anti-obesity pill The Guardian Brought to you by Google News. Read the rest of the article here Facebook Twitter Pinterest